Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” in some content and links to transition updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2 on the study-record error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site’s footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedData-sharing statements are removed, and a broad list of study metadata (including eligibility criteria, locations, and listed conditions/MeSH terms) is deleted. This changes how the trial's scope and access information are presented.SummaryDifference20%

- Check50 days agoChange DetectedThe site revision tag was updated from v3.6.6 to v3.7.0, signaling a software update. This appears to be a maintenance revision with no visible changes to page content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.